Targeting the $5 BILLION Soft Tissue Repair Market

Chitogenx is in the regulatory lead for regenerative products

Sponsored
Message: SmallCap 60: Chitogenx (CHGX: CSE) (CHNXF: OTCQB) Increases FDA Regulatory Lead For Soft Tissue Repair Trials

SmallCap 60: Chitogenx (CHGX: CSE) (CHNXF: OTCQB) Increases FDA Regulatory Lead For Soft Tissue Repair Trials

posted on Sep 19, 2022 02:17PM

Share
New Message
Please login to post a reply